Wednesday 27 November 2013

China Household Water Purifier Industry Report, 2013-2016

ResearchMoz.us include new market research report"China Household Water Purifier Industry Report, 2013-2016" to its huge collection of research reports.
 
The frequency of water pollution incidents arouses public’s growing concern over the quality of drinking water, calling for increasingly demanding quality of drinking water. Thus, the household water purifier market has got boosted. In 2008-2013Q1, China household water purifier market kept growing by more than 30%. 

As of late 2012, the scale of China household water purifier market approximated RMB15 billion, with low- and medium-range products such water purifier as mainstream priced at roughly RMB2, 300 on average. As China water purifier market is witnessing an improving environment, the industry is expected to be regulated progressively and grow towards mid-and high-range tide. 

Thus far, there are many industrial players in the regard in China. But most of them are small and micro businesses. In China’s household water purifier market, a few of big shots such as Midea, Qinyuan and Angel Group are occupying a lion’s share. Among the top 10 homegrown water purifier brands in 2012, the market share of the top 4 stood at a combined market share over 79%. In particular, Midea water purifier swept the market share of 29.93%, topping the list by retail volume. 
 
Browse Houseware Related Reports At :  http://www.researchmoz.us/housewares-market-reports-126.html

The report highlights the market scale, import & export, price and competition pattern, and channel development of China household water purifier industry, and studies three foreign companies including Pentair, Coway and Ecowater Systems Ltd., as well as 12 domestic peers like Midea, Shanghai Canature Environmental Products Co., Ltd., Beijing Origin Water Technology, Qinyuan, Angel Group and Sacon Group. 

Water treatment equipments of Shanghai Canature Environmental Products cover household and commercial water treatment products with the brands of Canature and Bentair. As of late 2012, the annual capacity of water treatment equipment assembly and parts hit 240,000 sets/units. Thus far, the company’s intelligent household whole house water treatment equipment, commercial water dispenser and the kit and supporting utility facilities are under construction and, it is expected to achieve the full capacity in late March of 2014. 
 
At present, the company’s ancillary products are “Origin Water” water purifiers which are mainly produced by its holding subsidiary-Beijing Originwater Technology Co.,Ltd. with the annual capacity approximating 500,000 sets in 2010. In the first half year of 2013, the revenue from water purifier sales business of the company skyrocketed by 440.14% year-on-year to RMB37.5826 million.
 
About Us:

ResearchMoz is the one stop online destination to find and buy market research reports. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets.

Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:
Email: sales@researchmoz.us
WebSite: http://www.researchmoz.us/
Blog: http://deepmarketresearchreports.blogspot.com/
http://medicaldevicesmarket.blogspot.com/

Monday 18 November 2013

China Mouse Nerve Growth Factor Injection Market Analysis

Researchmoz presents this most up-to-date research on"China Mouse Nerve Growth Factor Injection Market Analysis".The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the Remote Patient Monitoring Market.

China mouse nerve growth factor injection market analysis is an invaluable asset for anyone who wants to invest in the mouse nerve growth factor injection industry, to import into/from China, to build factories in China, to partner with one of the key Chinese corporations, or to compete in the segment. The report provides in-depth analysis and detailed insight into the mouse nerve growth factor injection industry, market drivers, key enterprises and their strategies, as well as technologies and investment status, risks and trends. 

Data sources: National statistics organizations, market research (monitoring) center, industry associations (institutes), import/export statistics organizations. 

Browse Reports In Pharmaceutical

 
Global Radio Pharmaceutical market to grow at a CAGR of 18.39 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Radio Pharmaceutical market has also been witnessing the increasing demand for radiopharmaceuticals. However, the short half-life could pose a challenge to the growth of this market.Global Radio Pharmaceutical Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Radio Pharmaceutical market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. 
 
 
The report firstly introduced Medical stone  basic information included Medical stone definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Medical stone  industry policy and plan, Medical stone  product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Medical stone  capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Medical stone  products customers application capacity market position company contact information etc company related information, then collect all these manufacturers data and listed Global and China Medical stone  capacity production capacity market share production market share supply demand shortage import export consumption etc data statistics, and then introduced Global and China Medical stone 2009-2018 capacity production price cost profit production value gross margin etc information. 
 
Data periods: Recent 3 to 5 years. 

Chapters: 

Chapter 1 Product Overview of mouse nerve growth factor injection  

Chapter 2 Environmental Analysis of the mouse nerve growth factor injection Industry 

Chapter 3 Upstream and Downstream Industry Chains of mouse nerve growth factor injection 

Chapter 4 Development Trend of mouse nerve growth factor injection Technology and Technique 
 
For More Reports On Pharmaceuticals Please Visit At : http://www.researchmoz.us/pharmaceutical-market-reports-38.html 

Chapter 5 Summary of the Domestic Market of mouse nerve growth factor injection  

Chapter 6 Major Manufacturers and Distributors of mouse nerve growth factor injection 

Chapter 7 Domestic Projects Proposed & Under Construction and Latest News on Domestic Competitors of mouse nerve growth factor injection 

Chapter 8 Foreign Market Analysis of mouse nerve growth factor injection 

Chapter 9 Future Development Forecasts and Investment Prospects of the mouse nerve growth factor injection Industry 

Chapter 10 Investment Risks and Preventive Measures of the mouse nerve growth factor injection Industry 

Knowledge is power. If you want to invest in, import into/from, partner with, or compete against any of the companies in this field, then China mouse nerve growth factor injection market analysis is required reading.
 

China Tourism Industry Report, 2013-2017

Researchmoz presents this most up-to-date research on"China Tourism Industry Report, 2013-2017".The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the Remote Patient Monitoring Market.

China tourism market has gained momentum in recent years, with the CAGR of 26.2% between 2009 and 2012. In 2012, the revenue in China tourism industry approximated RMB2.6 trillion, up 15.1% year-on-year.

China is at the turning point for economic restructuring and upgrading, leading to the economic growth slowdown but still in a robust way. Coupled with the improvement of national income level, the tourism industry of China witnesses consolidated growth, with the estimated revenue in 2013 growing by 14.3% year-on-year.
 
Reports Related to Travel Services : 
 

The report provides detailed market analysis, information and insights, including:
  • Historic and forecast tourist volumes covering the entire British travel and tourism sector
  • Detailed analysis of tourist spending patterns in the UK
  • The total, direct and indirect tourism output generated by each category within the British travel and tourism sector
  • Employment and salary trends for various categories in the UK's travel and tourism sector, such as accommodation, sightseeing and entertainment, foodservice, transportation, retail, travel intermediaries and others
  • Detailed market classification across each category, with analysis using similar metrics 
  • Detailed analysis of the airline, hotel, car rental and travel intermediaries industries

The report provides detailed market analysis, information and insights, including:
  • Historic and forecast tourist volumes covering the entire Indonesian travel and tourism sector
  • Detailed analysis of tourist spending patterns in Indonesia
  • The total, direct and indirect tourism output generated by each category within the Indonesian travel and tourism sector
  • Employment and salary trends for various categories in the Indonesian travel and tourism sector, such as accommodation, sightseeing and entertainment, foodservice, transportation, retail, travel intermediaries and others
  • Detailed market classification across each category, with analysis using similar metrics 
  • Detailed analysis of the airline, hotel, rar rental and travel intermediaries industries

Domestic Tourism Is Of Absolute Dominance

China tourism industry is made up of domestic tourism, inbound tourism and outbound tourism. Of these, domestic tourism is of absolute dominance in terms of either population or revenue. In 2012, the population of domestic tourism stood at 2.957 billion person-times, accounting for 93.2%, with the revenue hitting RMB2.2706 trillion or 87.8%. It is estimated that the number of domestic tourists in 2013 will claim 3.275 billion person-times, standing at 95.3%, with the targeted revenue increasing by 15.4% year-on-year to RMB2.62 trillion.
 
The Number of Star Hotels Demonstrates Shrinkage, while the Number of High-End Hotels Continue Expanding

In 2012, China had a total of 24,900 travel agencies with a year-on-year increase of 5.3%. In 2007-2012, the number of travel agencies in China witnessed stable growth momentum, with the CAGR of 4.8%. In particular, the number of star-class hotels saw a CAGR of negatively 3.5% from 2007 to 2012, three-star hotels 5.9%, four-star hotels 10.5%, and five-star hotels 13.9%.

The report touches on 20 major tourism enterprises, of which, three ones specialize in hotel running, one mainly involves in cruise business and the other 16 ones feature tourism industry. In 2012, the top three tourism companies by revenue came to Overseas Chinese Town (Group) Co., Ltd., China International Travel Group and China CYTS Tours Holding; the top three ones by net profit margin were as follows: Lijiang Yulong Tourism (33.2%), Emei Shan Tourism Company Limited (19.9%), Overseas Chinese Town (Group) Co., Ltd. (18.2%).
 
For More Travel Services Related Reports Click Here

In 2013Q1-Q3, the top three by revenue in the ranking list remained unchanged, but the top three ones by profitability made a change with Emei Shan Tourism Company Limited losing out to Dalian Sunasia Tourism Holding Co.,Ltd.. In 2013, the three- Overseas Chinese Town (Group) Co., Ltd., Huatian Hotel Group CO.,LTD and Dalian Sunasia Tourism Holding, experienced a year-on-year sharp rise of 66.7%, 24.8% and 17.6%, respectively. By contrast, another three ones, including XI'AN Tourism (Group), Guilin Tourism Corporation Limited and Wuhan Sante Cableways Group -witnessed the worst business performance in the same period, making them become the only three industrial players suffering severe losses.

The report highlights the followings:
  • status quo (revenue, number of tourists), development trend (next one to five years), and market segmentation (by product, region, etc.) of China tourism industry;
  • operation (development scale, revenue, revenue structure, distribution, the number of travel businesses and star-class hotels, the number of guest rooms and occupancy rate) of travel agencies and hotels;
  • 20 key Chinese tourism enterprises, travel agencies and hotels; focusing on their operation, revenue structure, latest dynamics and development outlook from different perspectives.

Monday 11 November 2013

Global Research On China Interventional Cardiovascular Device Industry Report, 2013 - 2015

Researchmoz presents this most up-to-date research on"China Interventional Cardiovascular Device Industry Report, 2013 - 2015".The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the Remote Patient Monitoring Market.

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republic of China, in 2012 cardiovascular disease deaths in China reached 3.5 million. The fast growing number of heart patients stimulated rapid growth in Chinese demand for interventional cardiac operation and coronary stent. 
 
China's PCI (percutaneous coronary intervention) surgeries increased from 25,000 cases in 2002 to about 531,000 cases in 2012; the number of coronary stent implantation rose from 40,000 units in 2002 to approximately 640,000 units in 2012. In 2007-2012 China's cardiovascular stent market size grew at an AAGR of 20.3%. 

In China, interventional cardiovascular devices are dominated by cardiovascular stent. Currently, the top three companies in China's coronary stent market are respectively MicroPort, Lepu Medical and JW Medical; while supporting auxiliary devices such as catheter and guide wire feature low localization rate, mainly dependent on imports. In 2012, Chinese enterprises accounted for 66.8% of Chinese interventional cardiovascular device market share, followed by foreign counterparts with 33.2%. 
 
Related Reports : 
 
MediPoint: Renal Denervation - EU Analysis and Market Forecasts  http://www.researchmoz.us/medipoint-renal-denervation-eu-analysis-and-market-forecasts-report.html
 
Numerous medical device news sources and industry executives have proclaimed renal denervation to be the top medical device breakthrough of the past two years, and for good reason. Hypertension is one of the most prevalent chronic conditions worldwide, with some studies estimating that 50% of the adult population globally will have the disease in the next 20 years. With limited effectiveness from pharmacotherapy, medical device therapy has the potential for significant adoption in the treatment of resistive hypertension and uncontrolled hypertension, once efficacy and cost-effectiveness are proven. Additionally, the degree of blood pressure reduction found in long-term clinical trials from such a well-tolerated procedure has generated notable optimism about the interventions application in other conditions where hyperactivity of the sympathetic nervous system plays a significant role, such as congestive heart failure.
 
 
LVADs are the mechanical devices which are implanted into the abdomen or chest and attached to a weakened heart to help it pump. LVADs are now sometimes used as an alternative to transplantation. LVAD is suitable for bridge-to-transplant market, which extends the patient’s life until a suitable donor is found, and for destination market, where patients suffer from heart failure but are not eligible for heart transplants, may be due to their age or some other illness that might get aggravated by heart transplantation. Due to increasing demand for both BTT and DT, LVAD market is increasing tremendously. Also, with the rapid technological advancements in this segment, LVADs are expected to become a viable treatment option for heart failure patients in the future.

Interventional cardiovascular device is a sunrise industry, there lies strong clinical demand for safer and more effective interventional products, and thus the world's major manufacturers have invested heavily in research and development of new products. Bioabsorbable everolimus-eluting stent (BVS) has become the focus of attention. 
 
Abbott in September 2012 launched the world's first A bioabsorbable everolimus-eluting coronary stent system (ABSORB), expected to bring a revolutionary change in coronary artery disease (CAD) treatment; MicroPort's third-generation completely biodegradable drug-eluting stent Firehawk has completed clinical trials in China; Lepu Medical's completely biodegradable drug-eluting stent is also in active research and development.
 
For Latest Reports Click Here

Table of Content

1. Overview of Interventional Cardiovascular Device Industry
1.1 Definition
1.2 Product Types and Applications
1.3 Industry Chain

2. Status Quo of China Interventional Cardiovascular Device Industry
2.1 Overview 
2.2 Market Demand 
2.3 Import and Export
2.4 Competition Pattern
2.5 Profit
2.6 Entry Barriers
2.6.1 Technology 
2.6.2 Talent 
2.6.3 Patent 
2.6.4 Policy 
2.6.5 Market Access 

3. Development Environment for China Interventional Cardiovascular Device Industry
3.1 Policy Environment
3.1.1 Regulatory Policy
3.1.2 Industry Policy
3.2 Upstream and Downstream Sectors
3.2.1 Upstream
3.2.2 Downstream


 
 

Thursday 7 November 2013

Plastic Injection Molding Machine Industry Report, 2013

Researchmoz presents this most up-to-date research on"Global and China Plastic Injection Molding Machine Industry Report, 2013".The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the Remote Patient Monitoring Market.


The annual output of injection molding machines in China, the world’s largest injection molding machine producer, hit roughly 100,000 sets. However, impacted by the weakening demand for auto and household appliances downstream on the heels of slowdown in the growth of Chinese economy, China’s output of injection molding machines slowed down in growth since 2011H2, and even witnessed negative growth in 2012. Nevertheless, China injection molding machine market showed stable momentum from 2013Q2, with the expected annual output growing by around 2.5% over the preceding year.

Meanwhile, China also boasts a major trader of injection molding machines in the world. 2012 witnessed a notable turning point in terms of trading in China injection molding machine industry, with the export exceeding the import for the first time, and with the trade surplus amounting to USD111.85 million. In 2013, the trade surplus further expanded, with the value in the first eight months hitting USD150.30 million. This came as the following two aspects: firstly, more and more overseas manufacturers are establishing injection molding machine works in China, fueling the export of injection molding machines; secondly, China’s sluggish demand in recent two years caused the decline in import. Rather, some of western economies are emerging from its doldrums, creating better conditions for investment and generating import of injection molding machines. 

The report emphasizes the production , sales, and import & export of global and China injection molding machine industry, dwells on the market breakdown of all-electric, all-hydraulic and two-plate models, and highlights six international tycoons including Arburg, Sumitomo (SHI) Demag, Engel and NISSEI Plastic Industrial as well as 14 domestic enterprises including Haitian International Holdings Limited, The Chen Hsong Group, L.K. Technology Holdings Limited, Cosmos Machinery Enterprises Limited, FU CHUN SHIN Machinery Manufacture, Borch Machinery and Guangdong Yizumi Precision Machinery.
 
#####
 
Related Reports : 

Global and China All-Electric Injection Molding Machine Industry 2013 Deep Research Report http://www.researchmoz.us/global-and-china-all-electric-injection-molding-machine-industry-2013-deep-research-report-report.html
 
All-Electric Injection Molding Machine definition classification industry chain etc related information. Then introduced All-Electric Injection Molding Machine manufacturing technology and product specifications, And then summary statistics Global and China major All-Electric Injection Molding Machine manufacturers 2009-2016 All-Electric Injection Molding Machine capacity production supply demand shortage and All-Electric Injection Molding Machine selling price cost profit margin and production value, and also introduced International and China 13 manufacturers company basic information, 2009-2016 All-Electric Injection Molding Machine capacity production price cost profit margin production value Global China market share etc details information. 
Global and China Plastic Injection Molding Machine Industry 2012 Deep Research Report http://www.researchmoz.us/global-and-china-plastic-injection-molding-machine-industry-2012-deep-research-report-report.html

Plastic Injection Molding Machine basic information included Plastic Injection Molding Machine definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Plastic Injection Molding Machine industry policy and plan, Plastic Injection Molding Machine product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Plastic Injection Molding Machine capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Plastic Injection Molding Machine products customers application capacity market position company contact information etc company related information, then collect all these manufacturers data and listed China Plastic Injection Molding Machine capacity production 
 
#####

Arburg boasts the world’s leading injection molding machine producer which has established branches in Hong Kong, Shanghai and Shenzhen. In particular, the Shanghai outlet is its focus in China, providing mid to high-end products such as metal powder injection molding machines, liquid silicone injection molding machines, and thermal plastic injection molding machines in a modular approach. In Jul. 2013, Arburg set up injection molding machine spot warehouse in Shanghai, in an aim to offer better service for clients across Asia.

Sumitomo (SHI) Demag has four injection molding machine production bases located at Schwaig and Wiehe of Germany, Japan and Ningbo of China. In Aug.2013, Demag input EUR7 million in China earmarked for expanding the capacities of injection molding machines in the Ningbo base, with the targeted capacities increasing from 650 sets to 1,000-3,000 sets.

Haitian International Holdings Limited, the world’s largest injection molding machine manufacturer, has set up distribution networks in China, Germany, Brazil, Turkey, and Vietnam. In 2012, its output of injection molding machines hit 22,000 sets, with the sales amounting to RMB6.336 billion. In 2013, it planned to build the 12th and 13th branches in Ningbo specializing in the production of all-electric and large-sized injection molding machines, respectively.
 
For More Machinery Related Reports Please Visit At : http://www.researchmoz.us/machinery-market-reports-169.html

FU CHUN SHIN Machinery Manufacture, the largest injection molding machine manufacturer in Taiwan, owns three production bases in Ningbo, Dongguan and Taiwan, with the annual capacity hitting 3,160 sets. In 2012, the revenue of the company claimed NTD1.654 billion, of which, NTD1.012 billion from injection molding machine business. In Oct.2013, the company set a target to realize the revenue of NTD6 billion by 2018. In addition, it is poised to strength its commercial arm towards overseas market through building one to two injection molding machine production bases in Brazil and Indonesia in coming five years as well as three to five self-support footholds in the Philippines and India.
 
About Us :
 
 
Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.
ResearchMoz is the one stop online destination to find and buy market research reports.

We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets.
 
 
For More Information Kindly Contact:
Email: sales@researchmoz.us
WebSite: http://www.researchmoz.us/
http://strategicdefenceintelligence.blogspot.com
Wordpressblogg : http://seobhaktiresearch.wordpress.com